Document Detail


Monitoring of ventilation during the early part of cardiopulmonary exercise testing: the first step to detect central sleep apnoea in chronic heart failure.
MedLine Citation:
PMID:  17761455     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: To evaluate the prediction of nocturnal central sleep apnoea (CSA) syndrome from the presence of periodic breathing (PB) on diurnal monitoring of pre-exercise (cardiopulmonary exercise test [CPX]) parameters. CSA syndrome is commonly found in congestive heart failure (CHF) patients and has several prognostic and therapeutic implications but is frequently undiagnosed. Awake PB pattern is sometimes observed during the CPX cardiopulmonary monitoring period of gas exchanges in CHF patients referred to the stress test laboratory for routine peak VO2 determination. PATIENTS AND METHODS: Forty-five consecutive ambulatory patients (2 women/43 men; 60.2+/-11.7 years old) with clinically moderate to severe CHF (New York Heart Association [NYHA] class II/III: 22/23; mean+/-standard deviation left ventricular ejection fraction [LVEF]: 30.5+/-6.6%) underwent a classical maximal CPX test including a 2-min period (pre-test) of gas exchange monitoring and nocturnal ambulatory polygraphic monitoring. PB was defined when a cyclical pattern of VE, VO2, VCO2, was visually noted during the pre-exercise period and/or during the first 4 min of the CPX. CSA syndrome was retained as a central apnoea-plus-hypopnea index (cAHI) equal to or more than 10/h. The sleep study scoring procedure was done independently of the knowledge of the CPX results. Sensitivity, specificity and predictive values were calculated and receiver operating characteristic (ROC) curve analysis was constructed. RESULTS: Peak VO2 reached 16.4+/-5.2 mL kg(-1)min(-1) (55% of the theoretical value adjusted for gender and age). The polygraphy was completed and validated (at least five consecutive hours of sleep) in all cases. CSA syndrome was found in 28 (62%) patients (mean cAHI: 19.3+/-8.6/h). Sensitivity for the prediction of CSA syndrome reached 92.9% (two false-negative patients with a cAHI of nine) and specificity 94.1% with a predictive accuracy of 93.3%. The only false-positive patient suffered a moderate but significant obstructive sleep apnoea syndrome. Using ROC curve analysis, the W value reached 0.99 for the prediction of CSA from the presence of PB. The presence of CSA syndrome, using logistic regression analysis, is associated with a more severe functional status (NYHA: p<0.01, peak VO2: p<0.002), a lower basal and peak end-expiratory CO2 pressure (PETCO2, all p<0.03), a worse LVEF (p<0.01) and age equal to or more than 60 years (p<0.03). CONCLUSIONS: The observation of PB in the preliminary period of the CPX test in CHF patients appeared highly predictive of the presence of CSA syndrome during sleep and could prompt the use of polygraphic monitoring in severe CHF patients.
Authors:
Frédéric Roche; Delphine Maudoux; Yann Jamon; Jean-Claude Barthelemy
Related Documents :
15573835 - Prediction of peak oxygen uptake in patients fulfilling the 1994 cdc criteria for chron...
11849865 - Physical training modulates proinflammatory cytokines and the soluble fas/soluble fas l...
1768585 - Recombinant human erythropoietin therapy in pediatric patients receiving long-term peri...
8154425 - Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart...
6325355 - Maximal exercise tolerance after induced alkalosis.
12183505 - Smaller muscle atp reduction in women than in men by repeated bouts of sprint exercise.
Publication Detail:
Type:  Journal Article     Date:  2007-08-29
Journal Detail:
Title:  Sleep medicine     Volume:  9     ISSN:  1389-9457     ISO Abbreviation:  Sleep Med.     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-05-21     Completed Date:  2008-12-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100898759     Medline TA:  Sleep Med     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  411-7     Citation Subset:  IM    
Affiliation:
Service de Physiologie Clinique et de l'Exercice & Association de Recherche Synapse, CHU Nord, Niveau 6, Faculté de Médecine Jacques Lisfranc, Université Jean Monnet, F-42055 Saint-Etienne Cedex 2, France. Frederic.Roche@univ-st-etienne.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carbon Dioxide / blood
Cheyne-Stokes Respiration / diagnosis*,  etiology
Exercise Test*
Female
Heart Failure / complications,  diagnosis*
Humans
Male
Middle Aged
Monitoring, Ambulatory*
Oxygen / blood
Polysomnography*
Prospective Studies
Sensitivity and Specificity
Sleep Apnea, Central / diagnosis*,  etiology
Chemical
Reg. No./Substance:
124-38-9/Carbon Dioxide; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Application of videotape in the screening of obstructive sleep apnea in children.
Next Document:  Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome.